Need Help?
Join Our Mailing List| National Institute of Allergy and Infectious Diseases (NIAID) National Institutes of Health U.S. Department of Health and Human Services |
FOR IMMEDIATE RELEASE March 20, 2008 Contact: niaidnews@niaid.nih.gov |
NIAID MEDIA AVAILABILITY
NIAID to Convene HIV Vaccine Summit
Watch Live Via Webcast
| WHAT: |
On Tuesday, March 25, 2008, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, will host an HIV Vaccine Summit in Bethesda, Md. as an important step in the ongoing process to examine the current direction of HIV vaccine research. Through interactive panel discussions, NIAID and the scientific community will explore
Based on the panel discussions, NIAID is seeking specific recommendations on the types of research to foster and how to attract novel vaccine research ideas. Media registration to attend the summit in-person has closed; however, media are invited to watch the summit during a live Webcast. | |
| WHEN: |
Tuesday, March 25, 2008 | |
| WHERE: |
To view the online NIAID HIV Vaccine Webcast, visit the Summit Web page. | |
| CONTACT: | For more information, contact the NIAID Office of Communications at (301) 402-1663, niaidnews@niaid.nih.gov. |
NIAID is a component of the National Institutes of Health. NIAID supports basic and applied research to prevent, diagnose and treat infectious diseases such as HIV/AIDS and other sexually transmitted infections, influenza, tuberculosis, malaria and illness from potential agents of bioterrorism. NIAID also supports research on basic immunology, transplantation and immune-related disorders, including autoimmune diseases, asthma and allergies.